{"url_path":"/sec/aaql/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 Exhibits, Financial Statement Schedules**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","accession_number":"0001493152-26-033212","cik":"0001672571","ticker":"AAQL","issuer_name":"Antiaging Quantum Living Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","primary_entity_key":"0001672571","primary_entity_name":"Antiaging Quantum Living Inc."},"word_count":1567,"has_tables":true,"body_markdown":"**Item\n15. Exhibits, Financial Statement Schedules**\n\n \n\n3.1*\n \n[Certificate\nof Amendment of the Certificate of Incorporation (filed as exhibit to the Form 8-K filed with the SEC on June 21, 2024)](https://www.sec.gov/Archives/edgar/data/1672571/000149315224024714/ex3-1.htm)\n\n \n \n \n\n3.2*\n \n[By-laws\n(filed as an Exhibit to Form S-1 filed with the SEC on May 2, 2016)](https://www.sec.gov/Archives/edgar/data/1672571/000167257116000001/achisonarticlesbylaw.htm)\n\n \n \n \n\n10.1***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Barry Wan, as assignor, and\nEmpire Street Capital Inc., as assignee, incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement\non Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-1.htm)\n\n \n \n \n\n10.2***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., New Lite Ventures LLC, as\nassignor, and Atlantic Equity Holdings Inc., as assignee, incorporated by reference to Exhibit 10.2 to the Company’s Registration\nStatement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-2.htm)\n\n \n \n \n\n10.3***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd.,\nas assignor, Antiaging Doctor Hangzhou Holding Ltd., as original maker, and Atlantic Equity Holdings Inc., as assignee, incorporated\nby reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-3.htm)\n\n \n \n \n\n10.4***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd.,\nas assignor, Dao Ling Doctor (Zhejiang) Health Management Limited, as original maker, and Empire Street Capital Inc., as assignee,\nincorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-1 filed with the SEC on December\n12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-4.htm)\n\n \n \n \n\n10.5***\n \n[Unanimous\nWritten Consent of the Stockholder, dated November 25, 2025, incorporated by reference to Exhibit 10.5 to the Company’s Registration\nStatement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-5.htm)\n\n \n \n \n\n10.6***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Barry Wan, in the principal amount of $428,789.50,\nincorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1 filed with the SEC on December\n12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-6.htm)\n\n \n \n \n\n10.7***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and New Lite Ventures LLC, in the principal amount of\n$29,571.00, incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed with the SEC\non December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-7.htm)\n\n \n \n \n\n10.8***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount\nof $538,568.00, relating to Antiaging Doctor Hangzhou Holding Ltd., incorporated by reference to Exhibit 10.8 to the Company’s\nRegistration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-8.htm)\n\n \n \n \n\n10.9***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount\nof $287,174.00, relating to Dao Ling Doctor (Zhejiang) Health Management Limited, incorporated by reference to Exhibit 10.9 to the\nCompany’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-9.htm)\n\n \n \n \n\n10.10***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Tairan Baohe Insurance Sales Co., Ltd., in the principal\namount of $383,598.00, incorporated by reference to Exhibit 10.10 to the Company’s Registration Statement on Form S-1 filed\nwith the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-10.htm)\n\n \n \n \n\n31.1**\n \n[Certification\nof Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934,\nas Amended.](ex31-1.htm)\n\n \n \n \n\n31.2**\n \n[Certification\nof Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934,\nas Amended.](ex31-2.htm)\n\n \n \n \n\n32.1**\n \n[Certification\nof Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section\n906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n \n \n \n\n101.INS**\n \nInline\nXBRL Instance Document\n\n101.SCH**\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n101.CAL**\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF**\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB**\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE**\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nIncorporated by reference to the Company’s Form 8-K as filed with the SEC on June 21, 2024.\n\n \n\n**\nFiled herewith\n\n \n\n***\nIncorporated by reference to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.\n\n \n\n19\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nIn\naccordance with the Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its\nbehalf by the undersigned, thereunto duly authorized on the 14th day of July, 2026.\n\n \n\n \n**Antiaging\nQuantum Living Inc.**\n\n \n \n \n\n \nBy:\n*/s/\nBarry Wan*\n\n \n \nBarry\nWan, President\n\n \n \nChief\nExecutive Officer\n\n \n\nIn\naccordance with the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons on\nbehalf of the Registrant and in the capacities indicated and on the dates stated.\n\n \n\nDated:\nJuly 14, 2026\nBy:\n*/s/\nBarry Wan*\n\n \n \nBarry\nWan\n\n \n \nCEO,\nCFO, Sec. and Director\n\n \n\n20\n\n \n\n** **\n\n**EXHIBIT\nINDEX**\n\n \n\n3.1*\n \n[Certificate\nof Amendment of the Certificate of Incorporation (filed as exhibit to the Form 8-K filed with the SEC on June 21, 2024)](https://www.sec.gov/Archives/edgar/data/1672571/000149315224024714/ex3-1.htm)\n\n \n \n \n\n3.2*\n \n[By-laws\n(filed as an Exhibit to Form S-1 filed with the SEC on May 2, 2016)](https://www.sec.gov/Archives/edgar/data/1672571/000167257116000001/achisonarticlesbylaw.htm)\n\n \n \n \n\n10.1***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Barry Wan, as assignor, and\nEmpire Street Capital Inc., as assignee, incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement\non Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-1.htm)\n\n \n \n \n\n10.2***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., New Lite Ventures LLC, as\nassignor, and Atlantic Equity Holdings Inc., as assignee, incorporated by reference to Exhibit 10.2 to the Company’s Registration\nStatement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-2.htm)\n\n \n \n \n\n10.3***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd.,\nas assignor, Antiaging Doctor Hangzhou Holding Ltd., as original maker, and Atlantic Equity Holdings Inc., as assignee, incorporated\nby reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-3.htm)\n\n \n \n \n\n10.4***\n \n[Assignment\nand Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd.,\nas assignor, Dao Ling Doctor (Zhejiang) Health Management Limited, as original maker, and Empire Street Capital Inc., as assignee,\nincorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-1 filed with the SEC on December\n12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-4.htm)\n\n \n \n \n\n10.5***\n \n[Unanimous\nWritten Consent of the Stockholder, dated November 25, 2025, incorporated by reference to Exhibit 10.5 to the Company’s Registration\nStatement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-5.htm)\n\n \n \n \n\n10.6***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Barry Wan, in the principal amount of $428,789.50,\nincorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1 filed with the SEC on December\n12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-6.htm)\n\n \n \n \n\n10.7***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and New Lite Ventures LLC, in the principal amount of\n$29,571.00, incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed with the SEC\non December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-7.htm)\n\n \n \n \n\n10.8***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount\nof $538,568.00, relating to Antiaging Doctor Hangzhou Holding Ltd., incorporated by reference to Exhibit 10.8 to the Company’s\nRegistration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-8.htm)\n\n \n \n \n\n10.9***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount\nof $287,174.00, relating to Dao Ling Doctor (Zhejiang) Health Management Limited, incorporated by reference to Exhibit 10.9 to the\nCompany’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-9.htm)\n\n \n \n \n\n10.10***\n \n[Promissory\nNote, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Tairan Baohe Insurance Sales Co., Ltd., in the principal\namount of $383,598.00, incorporated by reference to Exhibit 10.10 to the Company’s Registration Statement on Form S-1 filed\nwith the SEC on December 12, 2025.](https://www.sec.gov/Archives/edgar/data/1672571/000149315225027486/ex10-10.htm)\n\n \n \n \n\n31.1**\n \n[Certification\nof Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934,\nas Amended.](ex31-1.htm)\n\n \n \n \n\n31.2**\n \n[Certification\nof Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934,\nas Amended.](ex31-2.htm)\n\n \n \n \n\n32.1**\n \n[Certification\nof Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section\n906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n \n \n \n\n101.INS**\n \nInline\nXBRL Instance Document\n\n101.SCH**\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n101.CAL**\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF**\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB**\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE**\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nIncorporated\nby reference to the Company’s Form 8-K as filed with the SEC on June 21, 2024.\n\n \n \n\n**\n\nFiled\nherewith\n\n \n\n***\nIncorporated by reference to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.\n\n \n\n21\n\n** **"}